Monday, June 15, 2026

BREAD OR BRICKS? : Why Kim Jong Un Is Spending Billions On Empty Skyscraper Shells While His People Starve

North Korea plans to build hundreds of thousands of housing units over five years, expanding on previous construction efforts.

North Korea Amplifies Anti-American Propaganda at Sinchon Museum for Victory Day

North Korea intensifies anti-American sentiment through the Sinchon Class Education Hall, emphasizing class education and self-defense.

US to Expand Tariffs on Steel and Auto Parts, Increasing Pressure on Korean Manufacturers

Trump's administration seeks input on expanding tariffs on steel, aluminum, and auto parts, impacting U.S. manufacturers and Korean suppliers.

Tag: botulinum toxin

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

Hugel holds ‘Letybo’ training in Indonesia to boost competitiveness and brand awareness

Hugel expands in Indonesia with a training program for Letybo, enhancing local medical professionals' skills and brand loyalty.

Hugel holds first regional symposium in Beijing, to tour key cities including Shanghai and Guangzhou

Hugel held a successful symposium in Beijing to enhance awareness of its Letybo product among Chinese medical professionals.

INIBO Launch: How This New Botulinum Toxin is Transforming the Aesthetic Market in Peru

Inibio launched its botulinum toxin product Inibo in Peru, marking a significant entry into the Latin American medical aesthetics market.

Huons BioPharma’s Botulinum Toxin HUTOX Set to Transform the Chinese Market

Huons BioPharma partners with iMaker Technology to supply botulinum toxin, aiming for a strong market presence in China.

Discover the Excellence of Botulax and Revolax at Thailand’s Largest Dermatology Conference

Hugel showcased its HA filler Revolax and botulinum toxin products at Thailand's largest dermatology conference, enhancing medical engagement.

Hugel’s Record-Breaking 2025 Financials: How Botulax and HA Fillers Drive 14% Revenue Growth

Hugel reports record 2025 financials with strong sales in toxins, fillers, and cosmetics, focusing on global market expansion.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in China Study

Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.